この画面を閉じる

文献元のページへ

LDH Cytotoxicity Detection Kit

使用文献

LDH Cytotoxicity Detection Kit(製品コード MK401)Citations

  • Infect Immun. 2005 ;73(7):3869-77.
    Tsuchiya K, Kawamura I, Takahashi A, Nomura T, Kohda C, Mitsuyama M.
    Listeriolysin O-induced membrane permeation mediates persistent interleukin-6 production in Caco-2 cells during Listeria monocytogenes infection in vitro.


  • Cancer Res. 2004 ;64(15):5442-8.
    Tsukahara T, Nabeta Y, Kawaguchi S, Ikeda H, Sato Y, Shimozawa K, Ida K, Asanuma H, Hirohashi Y, Torigoe T, Hiraga H, Nagoya S, Wada T, Yamashita T, Sato N.
    Identification of human autologous cytotoxic T-lymphocyte-defined osteosarcoma gene that encodes a transcriptional regulator, papillomavirus binding factor.


  • J Immunol. 2003 ;170(5):2557-63.
    Lee MJ, Yang CW, Jin DC, Chang YS, Bang BK, Kim YS.
    Bone morphogenetic protein-7 inhibits constitutive and interleukin-1 beta-induced monocyte chemoattractant protein-1 expression in human mesangial cells: role for JNK/AP-1 pathway.


  • Infect Immun. 2003 ;71(1):234-41.
    Ito Y, Kawamura I, Kohda C, Baba H, Nomura T, Kimoto T, Watanabe I, Mitsuyama M.
    Seeligeriolysin O, a cholesterol-dependent cytolysin of Listeria seeligeri, induces gamma interferon from spleen cells of mice.


  • Blood. 2002 ;100(12):3950-9.
    Kikuchi T, Maemondo M, Narumi K, Matsumoto K, Nakamura T, Nukiwa T.
    Tumor suppression induced by intratumor administration of adenovirus vector expressing NK4, a 4-kringle antagonist of hepatocyte growth factor, and naive dendritic cells.


  • Infect Immun. 2002 ;70(3):1334-41.
    Kohda C, Kawamura I, Baba H, Nomura T, Ito Y, Kimoto T, Watanabe I, Mitsuyama M.
    Dissociated linkage of cytokine-inducing activity and cytotoxicity to different domains of listeriolysin O from Listeria monocytogenes.


  • Infect Immun. 2002 ;70(1):107-13.
    Baba H, Kawamura I, Kohda C, Nomura T, Ito Y, Kimoto T, Watanabe I, Ichiyama S, Mitsuyama M.
    Induction of gamma interferon and nitric oxide by truncated pneumolysin that lacks pore-forming activity.


  • J Biol Chem. 2002 ;277(44):41817-26.
    Noda M, Yamashita S, Takahashi N, Eto K, Shen LM, Izumi K, Daniel S, Tsubamoto Y, Nemoto T, Iino M, Kasai H, Sharp GW, Kadowaki T.
    Switch to anaerobic glucose metabolism with NADH accumulation in the beta-cell model of mitochondrial diabetes. Characteristics of betaHC9 cells deficient in mitochondrial DNA transcription.


  • Exp Biol Med (Maywood). 2001 ;226(6):597-604.
    Zhang HM, Ou ZL, Yamamoto T.
    Anisodamine inhibits shiga toxin type 2-mediated tumor necrosis factor-alpha production in vitro and in vivo.


  • Hum Mol Genet. 2000 ;9(18):2683-9.
    Tabrizi SJ, Orth M, Wilkinson JM, Taanman JW, Warner TT, Cooper JM, Schapira AH.
    Expression of mutant alpha-synuclein causes increased susceptibility to dopamine toxicity.

参考文献

LDH Cytotoxicity Detection Kit
1) Cook, J. A. &Mitchell, J. B. (1989) Anal.Biochem. 179, 1-7.
2) Yuhas, J.M.,Toya, R.E. &Pazmino, N.H. (1974) J.Nal.Cancer Inst. 53, 465-468.
3) Parks, D.R. et al. (1979) Proc. Nail. Acad. Sci USA 76, 1979.
4) Jones, K. H. &Senll, J. A. (1985) J.Hislochem. Cytochem. 33, 77-79.
5) Oldham, R. K. et al. (1977) J. Natl. Cancer Inst. 58, 1061-1067.
6) Leibold,W. & Bridge, S. (1979) Z.Immunilalsforschung(Immunobiology) 155, 287-311.
7) Kolber,M. A. et al. (1988) J.Immunol.Meth. 108, 255-264.
8) Danks, A.M. et al.(1992) Molecular Brain Research 16, 168-172.
9) Szekeres, J., Pacsa, A.S. & Pejlsik, B. (1981) J.Immun.Meth. 40, 151-154.
10) Masanel, J.,Gomez-Lechon, M. J. & Castell, J. V. (1988) Toxic,in Vitro 2, 275-282.
11) Martin, A. & Clynes,M. (1991) In Vitro Cell Dev. Biol. 27A, 183-184.
12) Decker,T.& Lohmann-Mallhes, M. L. (1988) J.Immun.Meth. 15, 61-69.
13) Korzeniewski,C. & Callewaert,D.M. (1983) J.Immun.Meth. 64, 313-320.
14) Dubar,V. et al. (1993) Exp.Lung Res. 19, 345-359.
15) Kondo,T. et al. (1993) Toxic, in Vitro 7, 61-67.
16) Murphy,E.J.,Roberts, E.& Horrocks, L.A. (1993) Neuroscience 55, 597-605.
17) Courjaull, F. et al. (1993) Arch.Toxicol. 67, 338-346.
18) Shrivaslava, R. et al. (1992) Cell Biology and Toxicology 8, 157-170.
19) Gelderblom, W. C. A. et al. (1993) Fd.Chem.Toxic. 31, 407-414.
20) Thomas, J.P., Geiger, P. G. & Girolli,A.W. (1993) Journal ol Lipid Research 34, 479- 490.
21) Sasaki T. et al. (1992) Toxic,in Vitro 6, 451-457.
22) Goergen, J.L., Marc, A.& Engasser, J.M. (1993) Cytotechnology 11, 189-195.
23) Legrand, C. et al. (1992) J .Biotechnol. 25, 231-243.
24) Racher, A. J., Looby, D. & Grilfiths, J. B. (1990) Cytotechnology 3, 301-307.

この画面を閉じる